Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VIR Vir Biotechnology, Inc.

盘后交易 12-16 18:21:44 EST

6.48

-0.24

-3.57%

盘后6.48

+0.000.00%

18:09 EST

最高6.70	最低6.36	成交量159.68万
今开6.68	昨收6.72	日振幅5.06%
总市值9.02亿	流通市值6.13亿	总股本1.39亿
成交额1,040万	换手率1.69%	流通股本9,455万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VIR","market":"US","secType":"STK","nameCN":"Vir Biotechnology, Inc.","latestPrice":6.48,"timestamp":1765918800000,"preClose":6.72,"halted":0,"volume":1596831,"hourTrading":{"tag":"盘后","latestPrice":6.48,"preClose":6.48,"latestTime":"18:09 EST","volume":149196,"amount":968407.4243184,"timestamp":1765926573876},"delay":0,"floatShares":94554590,"shares":139125032,"eps":-3.622804,"marketStatus":"盘后交易","change":-0.24,"latestTime":"12-16 18:21:44 EST","open":6.68,"high":6.7,"low":6.36,"amount":10398890.822355,"amplitude":0.050595,"askPrice":6.7,"askSize":20,"bidPrice":6.45,"bidSize":279,"shortable":3,"etf":0,"ttmEps":-3.622804,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1765933200000},"marketStatusCode":4,"adr":0,"listingDate":1570766400000,"exchange":"NASDAQ","adjPreClose":6.72,"preHourTrading":{"tag":"盘前","latestPrice":6.57,"preClose":6.72,"latestTime":"09:16 EST","volume":70,"amount":466.260039,"timestamp":1765894594660},"postHourTrading":{"tag":"盘后","latestPrice":6.48,"preClose":6.48,"latestTime":"18:09 EST","volume":149196,"amount":968407.4243184,"timestamp":1765926573876},"volumeRatio":1.09613,"impliedVol":0.9052,"impliedVolPercentile":0.676},"requestUrl":"/m/hq/s/VIR/wiki","defaultTab":"wiki","newsList":[{"id":"1191239464","title":"Vir Biotechnology - 在交易完成时将收到5500万欧元的初始补偿款，并将获得4.95亿欧元的临床、监管及销售里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1191239464","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191239464?lang=zh_cn&edition=full","pubTime":"2025-12-17 05:19","pubTimestamp":1765919965,"startTime":"0","endTime":"0","summary":"Vir Biotechnology - 在交易完成时将收到5500万欧元的初始补偿款，并将获得4.95亿欧元的临床、监管及销售里程碑款项","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VIR","BK4139","BK4568","BK4535"],"gpt_icon":0},{"id":"1121272875","title":"Vir Biotechnology预计当前现金、现金等价物及投资将延续至2027年第四季度","url":"https://stock-news.laohu8.com/highlight/detail?id=1121272875","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121272875?lang=zh_cn&edition=full","pubTime":"2025-12-17 05:19","pubTimestamp":1765919953,"startTime":"0","endTime":"0","summary":"Vir Biotechnology预计当前现金、现金等价物及投资将延续至2027年第四季度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4535","BK4585","VIR","BK4568"],"gpt_icon":0},{"id":"1178858356","title":"Vir Biotechnology向Norgine授予慢性乙型肝炎德尔塔治疗候选药物在欧洲、澳大利亚和新西兰的独家商业许可，并达成全球成本分担协议以支持持续的Eclipse临床开发计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1178858356","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178858356?lang=zh_cn&edition=full","pubTime":"2025-12-17 05:06","pubTimestamp":1765919195,"startTime":"0","endTime":"0","summary":"Vir Biotechnology向Norgine授予慢性乙型肝炎德尔塔治疗候选药物在欧洲、澳大利亚和新西兰的独家商业许可，并达成全球成本分担协议以支持持续的Eclipse临床开发计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4535","VIR","BK4585","BK4139"],"gpt_icon":0},{"id":"1152383992","title":"Vir Biotechnology宣布Eclipse 1三期试验的患者招募完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1152383992","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152383992?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:01","pubTimestamp":1762174905,"startTime":"0","endTime":"0","summary":"Vir Biotechnology宣布Eclipse 1三期试验的患者招募完成，该试验旨在治疗慢性乙型肝炎δ。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4535","BK4585","VIR"],"gpt_icon":0},{"id":"1178018455","title":"Vir Biotechnology将在2025年11月5日发布企业更新及2025年第三季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1178018455","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178018455?lang=zh_cn&edition=full","pubTime":"2025-10-23 04:06","pubTimestamp":1761163572,"startTime":"0","endTime":"0","summary":"Vir Biotechnology将在2025年11月5日发布企业更新及2025年第三季度财务业绩。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","BK4535","BK4585","VIR"],"gpt_icon":0},{"id":"1199143749","title":"Vir Biotechnology宣布PSMA靶向Pro-Xten®双掩蔽T细胞接合器Vir-5500联合雄激素受体通路抑制剂治疗转移性前列腺癌的1期试验第3部分首位患者开始给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1199143749","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199143749?lang=zh_cn&edition=full","pubTime":"2025-10-10 04:07","pubTimestamp":1760040448,"startTime":"0","endTime":"0","summary":"Vir Biotechnology宣布，其PSMA靶向Pro-Xten®双掩蔽T细胞接合器Vir-5500联合雄激素受体通路抑制剂治疗转移性前列腺癌的1期试验第3部分已完成首位患者给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","BK4568","BK4585","BK4139","BK4535"],"gpt_icon":0},{"id":"1138663622","title":"Vir Biotechnology, Inc.：美国银行全球研究将评级从中性上调至买入，目标价从12美元上调至14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138663622","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138663622?lang=zh_cn&edition=full","pubTime":"2025-08-27 19:14","pubTimestamp":1756293249,"startTime":"0","endTime":"0","summary":"美国银行全球研究将Vir Biotechnology, Inc.的投资评级从中性上调至买入，同时将目标价格从12美元上调至14美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4568","VIR","BK4139","BK4585"],"gpt_icon":0},{"id":"2551191403","title":"Vir Biotechnology, Inc.盘中异动 急速跳水5.00%报5.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551191403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551191403?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:12","pubTimestamp":1752603169,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时12分，Vir Biotechnology, Inc.股票出现异动，股价大幅下挫5.00%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Kairos Pharma, Ltd.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3260.49%、2034.55%、1552.67%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为444.11%、116.77%、75.50%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716021249a44ce5bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716021249a44ce5bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","BK4585","VIR","BK4568"],"gpt_icon":0},{"id":"2550952456","title":"Vir Biotechnology, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952456?lang=zh_cn&edition=full","pubTime":"2025-07-11 23:03","pubTimestamp":1752246223,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日23时03分，Vir Biotechnology, Inc.股票出现波动，股价大幅下挫5.06%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。其相关个股中，Mink Therapeutics, Inc.、Cel-Sci Corporation、Alterity Therapeutics Limited涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为515.38%、238.83%、83.04%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、74.61%、35.73%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711230343953eec2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711230343953eec2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","BK4585","BK4535","VIR"],"gpt_icon":0},{"id":"2550653515","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.09%报5.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653515?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:38","pubTimestamp":1752068321,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时38分，Vir Biotechnology, Inc.股票出现异动，股价急速拉升5.09%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Calidi Biotherapeutics, Inc.、Prokidney Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为629.20%、541.66%、401.21%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Prokidney Corp.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为56.72%、23.86%、19.80%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213841979fb72c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213841979fb72c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR","BK4535","BK4568","BK4585","BK4139"],"gpt_icon":0},{"id":"2548868018","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548868018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548868018?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:20","pubTimestamp":1751386819,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时20分，Vir Biotechnology, Inc.股票出现异动，股价急速上涨5.16%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200201997961ca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070200201997961ca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4568","BK4139","BK4535","VIR"],"gpt_icon":0},{"id":"2546402258","title":"Vir Biotechnology, Inc.盘中异动 股价大涨5.25%报5.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546402258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546402258?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:53","pubTimestamp":1750794795,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时53分，Vir Biotechnology, Inc.股票出现波动，股价急速上涨5.25%。截至发稿，该股报5.32美元/股，成交量59.5178万股，换手率0.43%，振幅4.26%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为1.91%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625035316978d455f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625035316978d455f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","BK4535","BK4585","VIR"],"gpt_icon":0},{"id":"2545446702","title":"Vir Biotechnology, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545446702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545446702?lang=zh_cn&edition=full","pubTime":"2025-06-24 00:33","pubTimestamp":1750696439,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日00时33分，Vir Biotechnology, Inc.股票出现波动，股价快速跳水5.07%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为2760.08%、2083.48%、778.64%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为273.41%、79.75%、71.02%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003359a4b987ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624003359a4b987ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4535","BK4585","VIR","BK4568"],"gpt_icon":0},{"id":"2518766872","title":"Vir Biotechnology, Inc.盘中异动 急速跳水5.01%报7.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518766872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518766872?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:46","pubTimestamp":1741617967,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时46分，Vir Biotechnology, Inc.股票出现异动，股价快速跳水5.01%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3490.39%、768.51%、666.04%，振幅较大的相关个股有Scisparc Ltd.、Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc，振幅分别为45.34%、41.36%、40.33%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022460798a2af6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022460798a2af6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VIR","BK4568","BK4535","BK4585"],"gpt_icon":0},{"id":"2517348985","title":"Vir Biotechnology, Inc.盘中异动 下午盘快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517348985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517348985?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:23","pubTimestamp":1741119820,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时23分，Vir Biotechnology, Inc.股票出现波动，股价大幅拉升5.04%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042340a25f66de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042340a25f66de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4568","VIR","BK4139","BK4585"],"gpt_icon":0},{"id":"2516077652","title":"Vir Biotechnology, Inc.盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516077652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516077652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:52","pubTimestamp":1741027951,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时52分，Vir Biotechnology, Inc.股票出现异动，股价急速下挫5.01%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4444.65%、200.45%、179.81%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025231abe67d4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304025231abe67d4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR","BK4139","BK4585","BK4535","BK4568"],"gpt_icon":0},{"id":"2516480135","title":"Vir Biotechnology, Inc.2024财年实现净利润-5.22亿美元，同比增加15.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516480135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516480135?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931287,"startTime":"0","endTime":"0","summary":"3月3日，Vir Biotechnology, Inc.公布财报，公告显示公司2024财年净利润为-5.22亿美元，同比增加15.12%；其中营业收入为74.21百万美元，同比减少13.89%，每股基本收益为-3.83美元。机构评级：截至2025年3月3日，当前有8家机构对Vir Biotechnology, Inc.目标价做出预测，其中目标均价为32.00美元，其中最低目标价为14.00美元，最高目标价为110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000214abe4acf8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000214abe4acf8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIR"],"gpt_icon":0},{"id":"2516307997","title":"巴克莱：维持Vir Biotechnology(VIR.US)评级，由增持调整至增持评级, 目标价由26.00美元调整至31.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516307997","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516307997?lang=zh_cn&edition=full","pubTime":"2025-03-01 06:03","pubTimestamp":1740780193,"startTime":"0","endTime":"0","summary":"巴克莱：维持Vir Biotechnology(VIR.US)评级，由增持调整至增持评级, 目标价由26.00美元调整至31.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01060348470365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VIR"],"gpt_icon":0},{"id":"2514373228","title":"HC Wainwright & Co.：重申Vir Biotechnology(VIR.US)评级，由买入调整至买入评级, 目标价由110.00美元调整至110.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373228","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514373228?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:13","pubTimestamp":1740755582,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Vir Biotechnology(VIR.US)评级，由买入调整至买入评级, 目标价由110.00美元调整至110.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28231348467203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VIR"],"gpt_icon":0},{"id":"2514385741","title":"Vir Biotechnology, Inc.盘中异动 急速拉升5.98%报9.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385741?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:31","pubTimestamp":1740666662,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时31分，Vir Biotechnology, Inc.股票出现波动，股价急速上涨5.98%。Vir Biotechnology, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Vir Biotechnology, Inc.公司简介：Vir Biotechnology Inc 是一家免疫学公司，专注于结合尖端技术治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310298950fe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722310298950fe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4568","BK4585","VIR","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vir.bio","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.1936},{"period":"3month","weight":0.3827},{"period":"6month","weight":0.2898},{"period":"1year","weight":-0.098},{"period":"ytd","weight":-0.0845}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vir Biotechnology, Inc.于2016年4月7日根据特拉华州法律注册成立。该公司是一家免疫学公司，专注于结合前沿技术来治疗和预防严重传染病和其他严重疾病，包括病毒相关疾病。该公司的目标是通过两种基本方式实现这一目标——第一，通过开发强大的抗体疗法，第二，通过基于T细胞的病毒载体平台在体内产生独特的T细胞反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.477739},{"month":2,"riseRate":0.333333,"avgChangeRate":0.037395},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121524},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.08783},{"month":5,"riseRate":0.666667,"avgChangeRate":0.058008},{"month":6,"riseRate":0.5,"avgChangeRate":0.020036},{"month":7,"riseRate":0.666667,"avgChangeRate":-0.044477},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.0277},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.115495},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.03118},{"month":11,"riseRate":0.857143,"avgChangeRate":0.105555},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.042704}],"exchange":"NASDAQ","name":"Vir Biotechnology, Inc.","nameEN":"Vir Biotechnology, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vir Biotechnology, Inc.(VIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vir Biotechnology, Inc.,VIR,Vir Biotechnology, Inc.股票,Vir Biotechnology, Inc.股票老虎,Vir Biotechnology, Inc.股票老虎国际,Vir Biotechnology, Inc.行情,Vir Biotechnology, Inc.股票行情,Vir Biotechnology, Inc.股价,Vir Biotechnology, Inc.股市,Vir Biotechnology, Inc.股票价格,Vir Biotechnology, Inc.股票交易,Vir Biotechnology, Inc.股票购买,Vir Biotechnology, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vir Biotechnology, Inc.(VIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vir Biotechnology, Inc.(VIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}